M
Michael Goggins
Researcher at Johns Hopkins University
Publications - 378
Citations - 52451
Michael Goggins is an academic researcher from Johns Hopkins University. The author has contributed to research in topics: Pancreatic cancer & Cancer. The author has an hindex of 111, co-authored 358 publications receiving 45785 citations. Previous affiliations of Michael Goggins include Johns Hopkins University School of Medicine & Fred Hutchinson Cancer Research Center.
Papers
More filters
Journal ArticleDOI
Correction: Vitamin D Metabolic Pathway Genes and Pancreatic Cancer Risk
Hannah Arem,Kai Yu,Xiaoqin Xiong,Kristin A. Moy,Neal D. Freedman,Susan T. Mayne,Demetrius Albanes,Laufey T. Amundadottir,Alan A. Arslan,Melissa A. Austin,William R. Bamlet,Laura Beane-Freeman,Paige M. Bracci,Federico Canzian,Stephen J. Chanock,Michelle Cotterchio,Eric J. Duell,Steve Gallinger,Graham G. Giles,Michael Goggins,Phyllis J. Goodman,Patricia Hartge,Manal M. Hassan,Kathy J. Helzlsouer,Brian E. Henderson,Elizabeth A. Holly,Robert N. Hoover,Eric J. Jacobs,Aruna Kamineni,Alison P. Klein,Eric A. Klein,Laurence N. Kolonel,Donghui Li,Núria Malats,Satu Männistö,Marjorie L. McCullough,Sara H. Olson,Irene Orlow,Ulrike Peters,Gloria M. Petersen,Miquel Porta,Gianluca Severi,Xiao-Ou Shu,Stephen K. Van Den Eeden,Kala Visvanathan,Emily White,Herbert Yu,Anne Zeleniuch-Jacquotte,Wei Zheng,Geoffrey S. Tobias,Dennis Maeder,Michelle Brotzman,Harvey A. Risch,Joshua N. Sampson,Rachael Z. Stolzenberg-Solomon +54 more
TL;DR: Three authors are not included in the author byline.
Journal ArticleDOI
Screening for Pancreatic Ductal Adenocarcinoma: Are We Asking the Impossible?—Letter
Bryson W. Katona,Randall E. Brand,Marcia I. Canto,Amitabh Chak,James J. Farrell,Fay Kastrinos,Anil K. Rustgi,Elena M. Stoffel,Sapna Syngal,Michael Goggins +9 more
TL;DR: Caldwell et al. as discussed by the authors highlight several challenges associated with employing a pancreatic cancer screening test, including questionable assumptions in their study, especially regarding individuals at high risk of pancreatic cancers, limit their conclusions.
Agnostic Pathway/Gene Set Analysis of Genome-Wide Association Data Identifies Associations for Pancreatic Cancer
Naomi Walsh,Han Zhang,Paula L. Hyland,Qi Yang,Evelina Mocci,Mingfeng Zhang,Erica J. Childs,Irene Collins,Zhaoming Wang,Alan A. Arslan,Laura Beane-Freeman,Paige M. Bracci,Paul Brennan,Federico Canzian,Eric J. Duell,Steven Gallinger,Graham G. Giles,Michael Goggins,Gary E. Goodman,Phyllis J. Goodman,Rayjean J. Hung,Charles Kooperberg,Robert C. Kurtz,Núria Malats,Loic LeMarchand,Rachel E. Neale,Sara H. Olson,Ghislaine Scelo,Xiao O. Shu,Stephen K. Van Den Eeden,Kala Visvanathan,Emily White,Wei Zheng,Demetrius Albanes,Gabriella Andreotti,Ana Babic,William R. Bamlet,Sonja I. Berndt,Ayelet Borgida,Marie-Christine Boutron-Ruault,Lauren K. Brais,Bas Bueno-de-Mesquita,Julie E. Buring,Kari G. Chaffee,Stephen J. Chanock,Sean Cleary,Michelle Cotterchio,Lenka Foretova,Charles S. Fuchs,J. Michael Gaziano,Edward Giovannucci,Thilo Hackert,Christopher A. Haiman,Patricia Hartge,Manal Hasan,Kathy J. Helzlsouer,Joseph M. Herman,Ivana Holcatova,Elizabeth A. Holly,Robert N. Hoover,Vladimir Janout,Eric A. Klein,Daniel A. Laheru,I-Min Lee,Lingeng Lu,Satu Männistö,Roger L. Milne,Ann L. Oberg,Irene Orlow,Alpa V. Patel,Ulrike Peters,Miquel Porta,Francisco X. Real,Nathaniel Rothman,Howard D. Sesso,Gianluca Severi,Debra T. Silverman,Oliver Strobel,Malin Sund,Mark D. Thornquist,Geoffrey S. Tobias,Jean Wactawski-Wende,Nicholas J. Wareham,Elisabete Weiderpass,Nicolas Wentzensen,William Wheeler,Herbert Yu,Anne Zeleniuch-Jacquotte,Peter Kraft,Donghui Li,Eric J. Jacobs,Gloria M. Petersen,Brian M. Wolpin,Harvey A. Risch,Laufey T. Amundadottir,Kai Yu,Alison P. Klein,Rachael Z. Stolzenberg-Solomon +97 more
TL;DR: In this article, a large agnostic pathway-based meta-analysis of GWAS data using the summary-based adaptive rank truncated product method was conducted to identify gene sets and pathways associated with pancreatic ductal adenocarcinoma (PDAC).
Journal ArticleDOI
Examination of ATM, BRCA1, and BRCA2 promoter methylation in patients with pancreatic cancer.
Cancan Zhou,Nancy Porter,Michael Borges,Christian Gauthier,Lindsey Ferguson,Bo Huang,Neha Nanda,Jin He,Daniel A. Laheru,Ralph H. Hruban,Michael Goggins,Alison P. Klein,Alison P. Klein,Nicholas J. Roberts +13 more
TL;DR: It is revealed that constitutive germline methylation of promoter CpG islands is rare in pancreatic cancer, well below levels found in patients who have inherited promoter methylation.